Published in Nat Rev Microbiol on January 01, 2005
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe (2007) 3.25
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol (2006) 3.15
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol (2006) 2.79
Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog (2008) 2.77
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34
Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol (2006) 2.33
Molecular targets for flavivirus drug discovery. Antiviral Res (2008) 2.32
The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog (2010) 2.28
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16
Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity. Curr Opin Struct Biol (2005) 2.06
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. J Virol (2016) 2.03
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog (2008) 2.00
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis (2011) 1.92
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol (2008) 1.83
The human antibody response to dengue virus infection. Viruses (2011) 1.79
Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71
A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog (2011) 1.70
The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med (2008) 1.67
Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog (2010) 1.67
The structural immunology of antibody protection against West Nile virus. Immunol Rev (2008) 1.63
Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol (2009) 1.60
A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J Virol (2008) 1.59
Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57
Natural strain variation and antibody neutralization of dengue serotype 3 viruses. PLoS Pathog (2010) 1.56
Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology (2011) 1.48
Retracted Recent advances in DENV receptors. ScientificWorldJournal (2013) 1.43
The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol (2005) 1.43
Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J (2005) 1.41
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol (2010) 1.41
The Src family kinase c-Yes is required for maturation of West Nile virus particles. J Virol (2005) 1.39
Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog (2007) 1.37
Membrane deformation and scission by the HSV-1 nuclear egress complex. Nat Commun (2014) 1.34
Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog (2011) 1.32
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? AIDS Res Hum Retroviruses (2011) 1.30
Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe (2009) 1.27
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol (2009) 1.27
Virus assembly, allostery and antivirals. Trends Microbiol (2010) 1.26
Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26
The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells. BMC Microbiol (2006) 1.25
Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. PLoS Pathog (2012) 1.24
Zika Virus: the Latest Newcomer. Front Microbiol (2016) 1.22
X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22
Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol (2007) 1.21
Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein. J Virol (2006) 1.20
Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J (2007) 1.20
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. PLoS Pathog (2013) 1.20
A novel small molecule inhibitor of hepatitis C virus entry. PLoS Pathog (2010) 1.16
Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol (2012) 1.15
Differential protein modulation in midguts of Aedes aegypti infected with chikungunya and dengue 2 viruses. PLoS One (2010) 1.14
Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. PLoS Negl Trop Dis (2012) 1.14
Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS One (2009) 1.13
New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol (2015) 1.10
West Nile virus. Clin Lab Med (2010) 1.10
DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis (2011) 1.09
Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res (2008) 1.09
Flavivirus cell entry and membrane fusion. Viruses (2011) 1.08
Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus. PLoS One (2012) 1.08
Antiviral peptides targeting the west nile virus envelope protein. J Virol (2006) 1.08
In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol (2010) 1.07
Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses. Biochem J (2007) 1.07
Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol (2008) 1.06
Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis. J Virol (2009) 1.06
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody. J Immunol (2009) 1.05
A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination. J Virol (2010) 1.05
Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J Virol (2011) 1.04
Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection. PLoS Pathog (2014) 1.03
Replication cycle and molecular biology of the West Nile virus. Viruses (2013) 1.03
Flaviviruses: braking the entering. Curr Opin Virol (2013) 1.02
Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. J Virol (2007) 1.02
Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus. J Virol (2005) 1.02
In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog (2010) 1.02
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol (2008) 1.02
Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses. J Biol Chem (2011) 1.02
Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly. J Virol (2006) 1.01
Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking. PLoS Negl Trop Dis (2009) 1.01
Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus. J Virol (2013) 1.01
Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J Biol Chem (2011) 1.01
Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol (2014) 1.00
CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog (2012) 1.00
Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect (2010) 1.00
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother (2012) 1.00
The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum. J Virol (2010) 0.99
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy. Front Microbiol (2014) 0.99
prM-antibody renders immature West Nile virus infectious in vivo. J Gen Virol (2011) 0.98
Mechanism and significance of cell type-dependent neutralization of flaviviruses. J Virol (2014) 0.98
E1 mutants identify a critical region in the trimer interface of the Semliki forest virus fusion protein. J Virol (2009) 0.97
Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay. J Virol (2006) 0.97
Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell Microbiol (2006) 0.96
Structure of the surface layer of the methanogenic archaean Methanosarcina acetivorans. Proc Natl Acad Sci U S A (2012) 0.96
Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region. Protein Expr Purif (2006) 0.95
Dimerization of flavivirus NS4B protein. J Virol (2014) 0.95
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Outcome of the first electron microscopy validation task force meeting. Structure (2012) 4.35
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11
Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86
Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66
Structures of immature flavivirus particles. EMBO J (2003) 3.62
Structure of West Nile virus. Science (2003) 3.48
Structure of the cell-puncturing device of bacteriophage T4. Nature (2002) 3.32
Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host. Cell (2004) 3.31
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol (2008) 3.27
The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26
The structure of the phage T4 DNA packaging motor suggests a mechanism dependent on electrostatic forces. Cell (2008) 3.07
The structure and evolution of the major capsid protein of a large, lipid-containing DNA virus. Proc Natl Acad Sci U S A (2002) 3.07
Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A (2010) 2.97
The tail structure of bacteriophage T4 and its mechanism of contraction. Nat Struct Mol Biol (2005) 2.82
Placement of the structural proteins in Sindbis virus. J Virol (2002) 2.81
Conservation of the capsid structure in tailed dsDNA bacteriophages: the pseudoatomic structure of phi29. Mol Cell (2005) 2.80
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Structural and functional similarities between the capsid proteins of bacteriophages T4 and HK97 point to a common ancestry. Proc Natl Acad Sci U S A (2005) 2.53
Giant Marseillevirus highlights the role of amoebae as a melting pot in emergence of chimeric microorganisms. Proc Natl Acad Sci U S A (2009) 2.52
Structural changes of envelope proteins during alphavirus fusion. Nature (2010) 2.32
Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32
Molecular architecture of the prolate head of bacteriophage T4. Proc Natl Acad Sci U S A (2004) 2.24
Picornavirus-receptor interactions. Trends Microbiol (2002) 2.23
Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science (2014) 2.16
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16
Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell (2006) 2.08
Three-dimensional structure of bacteriophage T4 baseplate. Nat Struct Biol (2003) 2.05
The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc Natl Acad Sci U S A (2004) 2.05
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03
Structural changes of bacteriophage phi29 upon DNA packaging and release. EMBO J (2006) 1.90
Structural studies of the giant mimivirus. PLoS Biol (2009) 1.88
Morphogenesis of the T4 tail and tail fibers. Virol J (2010) 1.86
Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J (2009) 1.85
Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci U S A (2004) 1.85
West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci U S A (2006) 1.83
The crystal structure of coxsackievirus A21 and its interaction with ICAM-1. Structure (2005) 1.82
Crystal structure of human enterovirus 71. Science (2012) 1.79
The structure of the ATPase that powers DNA packaging into bacteriophage T4 procapsids. Mol Cell (2007) 1.79
Structure of immature West Nile virus. J Virol (2007) 1.77
Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A (2013) 1.75
Bacteriophage phi29 scaffolding protein gp7 before and after prohead assembly. Nat Struct Biol (2003) 1.74
A structural and functional perspective of alphavirus replication and assembly. Future Microbiol (2009) 1.72
Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses. Structure (2006) 1.68
Construction and applications of yellow fever virus replicons. Virology (2005) 1.66
Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol (2005) 1.65
Interpretation of electron density with stereographic roadmap projections. J Struct Biol (2006) 1.64
Cryo-electron microscopy of the giant Mimivirus. J Mol Biol (2005) 1.61
Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol (2008) 1.59
Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57
Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proc Natl Acad Sci U S A (2010) 1.57
Mimivirus shows dramatic genome reduction after intraamoebal culture. Proc Natl Acad Sci U S A (2011) 1.54
The tail sheath structure of bacteriophage T4: a molecular machine for infecting bacteria. EMBO J (2009) 1.51
Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. Proc Natl Acad Sci U S A (2008) 1.51
Defining molecular and domain boundaries in the bacteriophage phi29 DNA packaging motor. Structure (2008) 1.47
The structure of porcine parvovirus: comparison with related viruses. J Mol Biol (2002) 1.46
Structure-guided insights on the role of NS1 in flavivirus infection. Bioessays (2015) 1.46
Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog (2012) 1.45
Structure of Sputnik, a virophage, at 3.5-Å resolution. Proc Natl Acad Sci U S A (2012) 1.45
Flavivirus capsid is a dimeric alpha-helical protein. J Virol (2003) 1.43
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol (2010) 1.41
Related giant viruses in distant locations and different habitats: Acanthamoeba polyphaga moumouvirus represents a third lineage of the Mimiviridae that is close to the megavirus lineage. Genome Biol Evol (2012) 1.40
Insight into DNA and protein transport in double-stranded DNA viruses: the structure of bacteriophage N4. J Mol Biol (2008) 1.39
The functional domains of bacteriophage t4 terminase. J Biol Chem (2004) 1.37
An icosahedral algal virus has a complex unique vertex decorated by a spike. Proc Natl Acad Sci U S A (2009) 1.35
Complexes of poliovirus serotypes with their common cellular receptor, CD155. J Virol (2003) 1.31
Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres. EMBO Rep (2011) 1.31
The structure of human parvovirus B19. Proc Natl Acad Sci U S A (2004) 1.30
Asymmetric binding of transferrin receptor to parvovirus capsids. Proc Natl Acad Sci U S A (2007) 1.30
Ultrastructural analysis of hepatitis C virus particles. Proc Natl Acad Sci U S A (2013) 1.29
Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem (2008) 1.28
Structure and function of the small terminase component of the DNA packaging machine in T4-like bacteriophages. Proc Natl Acad Sci U S A (2011) 1.28
Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease. J Biol Chem (2007) 1.25
Crystallographic insights into the autocatalytic assembly mechanism of a bacteriophage tail spike. Mol Cell (2009) 1.24
Capturing a flavivirus pre-fusion intermediate. PLoS Pathog (2009) 1.24
Heparin binding sites on Ross River virus revealed by electron cryo-microscopy. Virology (2005) 1.18
Three-dimensional structure and function of the Paramecium bursaria chlorella virus capsid. Proc Natl Acad Sci U S A (2011) 1.17
Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J Virol (2014) 1.17